BioSpace News Archive

Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE: PSTI), a leading regenerative medicine company, today reported positive topline results in its first study to evaluate the safety and exploratory efficacy of PLX-R18 in humans.

Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”), today announced the presentation of new scientific data and clinical analyses, including one podium presentation and 11 poster presentations, during the virtual Association for Research in Vision and Ophthalmology (ARVO) annual meeting, which will take place from May 1-7, 2021.

Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that it will present updates on its ongoing Phase 1 clinical trial evaluating COM701, a first-in-class therapeutic antibody targeting PVRIG, in an oral presentation at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting,

Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced the acceptance of an abstract discussing its pancreatic adenocarcinoma trial at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, which is taking place virtually from June 4 – 8, 2021.

DiaTrust™ received the U.S. Food and Drug Administration Emergency Use Authorization approval for their COVID-19 Point of Care antigen rapid test kit, DiaTrust™.

Angion Biomedica Corp and Vifor Pharma announced completion of enrollment for Angion’s AKI-002-15 study, a Phase 2 trial of ANG-3777 in patients at risk of cardiac-surgery associated acute kidney injury.

Modern Agriculture Platform (MAP), which provides farmers access to market-leading technologies, tripled in revenue from Q1 2020. Biologicals more than doubled in size, supported by the recent acquisition of Valagro

The global urinary tract infection treatment market is projected to amass a large amount of revenues in the coming years.

Transparency Market Research has published a new report on the global thoracic drainage devices market.

Transparency Market Research predicts that the global veterinary drugs market has a highly consolidative vendor landscape.